{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:58:11Z","timestamp":1785851891714,"version":"3.56.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1097\/01.coc.0000135180.94470.45","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T04:08:57Z","timestamp":1096517337000},"page":"481-484","source":"Crossref","is-referenced-by-count":6,"title":["Radiation Therapy Concurrent With Weekly Paclitaxel for Locoregionally Advanced Nasopharyngeal Carcinoma"],"prefix":"10.1097","volume":"27","author":[{"given":"Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Xiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Gui","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Wu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Ji","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0360-3016(89)90318-0","article-title":"Radiation therapy of nasopharyngeal carcinoma: prognostic factor based on a 10-years follow-up of 1302 patients.","volume":"16","author":"Zhang","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1083\/jcb.94.3.688","article-title":"Taxol binds to cellular microtubles.","volume":"94","author":"Manfredi","year":"1982","journal-title":"J Cell Biol"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-111-4-273","article-title":"Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.","volume":"111","author":"McGuire","year":"1989","journal-title":"Ann Intern Med"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/83.24.1797-a","article-title":"Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer.","volume":"83","author":"Holm","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/85.5.388","article-title":"Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group pilot study.","volume":"85","author":"Chang","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R6-10-20210128","first-page":"277","article-title":"Phase II evaluation of Taxol in advanced head and neck cancer: An Eastern Cooperative Oncology Group pilot study.","volume":"12","author":"Forastiere","year":"1993","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R7-10-20210128","first-page":"884","article-title":"Phase I study of paclitaxel administered over 96 h and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck.","volume":"15","author":"Forastiere","year":"1996","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R8-10-20210128","first-page":"5189","article-title":"Paclitaxel enhances in vitro radiation sensitivity of squamous carcinoma cell lines of the head neck.","volume":"56","author":"Leonard","year":"1996","journal-title":"Cancer Res"},{"key":"R9-10-20210128","first-page":"3564","article-title":"Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.","volume":"55","author":"Milas","year":"1997","journal-title":"Cancer Res"},{"issue":"suppl 3","key":"R10-10-20210128","first-page":"56","article-title":"Use of paclitaxel in squamous cell carcinoma of the head neck.","volume":"20","author":"Forastiere","year":"1993","journal-title":"Semin Oncol"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","article-title":"Common toxicity criteria: version 2. 0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.","volume":"47","author":"Trotti","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.1994.12.12.2682","article-title":"Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced nonsmall cell lung cancer.","volume":"12","author":"Choy","year":"1994","journal-title":"J Clin Oncol"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0360-3016(98)00533-1","article-title":"An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.","volume":"43","author":"Tischler","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0360-3016(97)00116-8","article-title":"Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer-results from a phase I trial.","volume":"38","author":"Hoffmann","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/1097-0142(19930601)71:11<3774::AID-CNCR2820711147>3.0.CO;2-0","article-title":"Investigation of Taxol as a potential radiation sensitizer.","volume":"71","author":"Choy","year":"1993","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-200410000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:33:23Z","timestamp":1785850403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200410000-00010"}},"subtitle":["Outcomes of a Phase I Trial"],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000135180.94470.45","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}